jv-1-36 jv-1-36 jv-1-36 is a ghrh antagonist that has been shown to inhibit endometriotic cell proliferation and survival, suggesting that ghrh antagonist may represent promising tools for treatment of endometriosis. jv-1-36 names iupac name n-(2-phenylacetyl)-l-tyrosyl-d-arginyl-l-α-aspartyl-l-alanyl-l-isoleucyl-4-chloro-l-phenylalanyl-l-threonyl-l-asparaginyl-n6-(aminoiminomethyl)-l-lysyl-o-methyl-l-tyrosyl-l-arginyl-l-lysyl-l-valyl-l-leucyl-(2s)-2-aminobutanoyl-l-glutaminyl-l-leucyl-l-seryl-l-alanyl-l-arginyl-l-lysyl-l-leucyl-l-leucyl-l-glutaminyl-l-α-aspartyl-l-isoleucyl-l-norleucyl-d-arginyl-n6-(aminoiminomethyl)-l-lysinamide other names phenylacetyl-(d-arg2·28,p-chloro-phe6,homoarg9·29,tyr(me)10,abu15,nle27)-sermorelin identifiers cas number 221377-79-3 properties chemical formula c172h284cln53o41 molar mass 3785.94 g·mol−1 except where otherwise noted, data are given for materials in their standard state (at 25 °c , 100 kpa). infobox references